NCT04972526 Resuscitative TEE Collaborative Registry
| NCT ID | NCT04972526 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-12-01 |
| Primary Completion | 2027-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-12-01 with a primary completion date of 2027-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE. The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings. The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Eligibility Criteria
Inclusion Criteria: * Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting. Exclusion Criteria: * Children (age under 18 years) * Vulnerable populations
Contact & Investigator
Felipe Teran, MD, MSCE
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT04972526 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04972526 currently recruiting?
Yes, NCT04972526 is actively recruiting participants. Contact the research team at cts95@cornell.edu for enrollment information.
Where is the NCT04972526 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT04972526 clinical trial?
NCT04972526 is sponsored by University of Pennsylvania. The principal investigator is Felipe Teran, MD, MSCE at Weill Medical College of Cornell University. The trial plans to enroll 1,000 participants.